De Novo JAK2 V617 F Positive AML: The Picture is Getting Clearer

Podobne knjige/članki

• The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients
  od: Lau, Winnie W. Y., et al.
  Izdano: (2015)
• Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7
  od: Fröhling, Stefan, et al.
  Izdano: (2006)
• Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm
  od: Peyro-Saint-Paul, Hélène, et al.
  Izdano: (2010)
• Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
  od: Stein, Brady L., et al.
  Izdano: (2011)
• Generalized Chorea and JAK2V617F Mutation‐Positive Myeloproliferative Disorders
  od: Betté, Sagari, et al.
  Izdano: (2020)